Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Obseva Sa Ordinary Shares (OBSV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 613,285
  • Shares Outstanding, K 36,440
  • Annual Sales, $ 16 K
  • Annual Income, $ -66,930 K
  • 36-Month Beta 1.55
  • Price/Sales 36,300.14
  • Price/Cash Flow N/A
  • Price/Book 3.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.46
  • Number of Estimates 5
  • High Estimate -0.41
  • Low Estimate -0.49
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +22.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.75 +11.75%
on 10/11/18
19.40 -9.28%
on 09/21/18
+0.12 (+0.69%)
since 09/19/18
3-Month
10.79 +63.11%
on 08/20/18
19.40 -9.28%
on 09/21/18
+1.04 (+6.28%)
since 07/19/18
52-Week
9.05 +94.48%
on 01/24/18
20.35 -13.51%
on 06/18/18
+7.11 (+67.78%)
since 10/19/17

Most Recent Stories

More News
Report: Developing Opportunities within Just Energy Group, Tetra Technologies, Domtar, MacroGenics, ObsEva SA, and Magic Software Enterprises -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Just Energy Group, Inc....

MGNX : 19.25 (-1.94%)
MGIC : 8.45 (-1.52%)
OBSV : 17.60 (+4.58%)
UFS : 44.68 (-0.62%)
TTI : 3.55 (-4.31%)
JE : 3.04 (-1.30%)
ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting

- Abstract featuring-IMPLANT2 data awarded Prize Paper by Society for Assisted Reproductive Technology (SART)

OBSV : 17.60 (+4.58%)
ObsEva SA Announces Phase 3 IMPLANT 2 Clinical Trial Results of Nolasiban in IVF to be Presented at Annual ASRM Meeting Tuesday October 9, 2018

EQNX::TICKER_START (:OBSV), EQNX::TICKER_END

OBSV : 17.60 (+4.58%)
ObsEva SA reports additional positive Phase 3 results of IMPLANT 2 trial showing significant increase of Live Birth Rate (LBR) following IVF with Single Embryo Transfer (SET)

- Phase 3 IMPLANT 2 trial results showed Live Birth Rate increased by up to 35% with Nolasiban treatment

OBSV : 17.60 (+4.58%)
ObsEva (OBSV) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in ObsEva SA (OBSV).

OBSV : 17.60 (+4.58%)
Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for the treatment of endometriosis-associated pain

- Linzagolix overall efficacy and safety maintained or improved at week 24

OBSV : 17.60 (+4.58%)
Can the Rally in ObsEva (OBSV) Shares Continue?

ObsEva SA (OBSV) has been on the move lately as the stock has risen by 22.7% in the past four weeks, and it is currently trading well above its 20-Day SMA.

OBSV : 17.60 (+4.58%)
ObsEva SA to Participate in September Investor Conferences

Geneva, Switzerland and Boston, MA - August 28, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics...

OBSV : 17.60 (+4.58%)
New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Constellium N.V, Just Energy Group, Hovnanian Enterprises, and First Majestic Silver -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ObsEva SA (NASDAQ:OBSV), Gran...

OBSV : 17.60 (+4.58%)
CSTM : 9.87 (-5.19%)
AG : 6.40 (+2.07%)
GTE : 3.39 (-1.74%)
JE : 3.04 (-1.30%)
HOV : 1.51 (-1.31%)
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018

ObsEva SA / ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 17.60 (+4.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade OBSV with:

Business Summary

ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland.

See More

Key Turning Points

2nd Resistance Point 18.77
1st Resistance Point 17.80
Last Price 17.60
1st Support Level 16.05
2nd Support Level 15.27

See More

52-Week High 20.35
Last Price 17.60
Fibonacci 61.8% 16.03
Fibonacci 50% 14.70
Fibonacci 38.2% 13.37
52-Week Low 9.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar